Skip to content
2000
Volume 12, Issue 4
  • ISSN: 1871-5273
  • E-ISSN: 1996-3181

Abstract

A frail patient is one who carries a sum of poly-pathologies, whose co-existence may shorten his life expectation. Diabetes mellitus type 2 and metabolic syndrome play a substantial role in it, but dementia has increasingly risen in importance. Interestingly, the insulin pathway was suggested to be responsible for the metabolic cascade that leads to amyloid-beta deposit and pathology. Nevertheless, a clear relationship between them was just experimentally, rather than clinically demonstrated. In this work the authors suggest a possible link between insulin, diabetes and Alzheimer’s disease, whose co-existence could be responsible for physical and cognitive decline but not for frailty. We suggest that these factors could be responsible for frailty only if senescence-associated.

Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/1871527311312040012
2013-06-01
2025-10-01
Loading full text...

Full text loading...

/content/journals/cnsnddt/10.2174/1871527311312040012
Loading

  • Article Type:
    Research Article
Keyword(s): Alzheimer’s disease; amyloid β-peptide42; diabetes mellitus type 2; insulin; tau
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test